Tau PET scans are offered primarily at academic medical centers, large teaching hospitals, and specialized neurology research facilities, though availability varies significantly by region. As of recent years, the imaging has expanded beyond research settings into clinical practice at some major institutions, but finding a location near you will require contacting neurology departments directly, as tau PET is not yet widely available in routine diagnostic settings like standard radiology centers or smaller hospitals.
The scan detects tau protein, a biomarker associated with Alzheimer’s disease and certain other neurodegenerative conditions. Because tau imaging is newer than amyloid PET and requires specialized equipment and expertise in nuclear medicine and dementia research, it remains concentrated in larger academic health systems and specialized memory disorder clinics. A patient in a major metropolitan area with a university medical center may have access, while someone in a rural area or smaller city may need to travel significant distances or explore whether a nearby institution can arrange the test through partnerships with larger centers.
Table of Contents
- Where Are Tau PET Scans Currently Available?
- Research Settings Versus Clinical Care
- Academic Medical Centers and Neurology Departments
- Accessing Tau PET: Referral and Insurance Considerations
- Limitations and Practical Challenges
- Comparing Tau PET to Other Amyloid and Neurodegeneration Imaging
- Finding a Tau PET Service: Practical Steps
- Frequently Asked Questions
Where Are Tau PET Scans Currently Available?
The availability of tau pet scanning has grown incrementally since the technology matured, but it remains clustered in research-intensive settings. University of California medical centers, Mayo Clinic locations, Johns Hopkins, Massachusetts General Hospital, and similar large academic institutions have been among the earlier adopters. Many major National Institutes of Health-funded Alzheimer’s research centers now offer tau PET, either as part of formal research protocols or as a clinical service for patients referred by their neurologist.
Private imaging centers and regional hospital chains have begun to offer tau PET in some markets, though this expansion is ongoing and inconsistent. Even where a facility has the PET camera equipment, it may not offer tau-specific tracers without nuclear medicine specialists trained in dementia imaging. This means availability is not simply a matter of geography—it also depends on whether the institution has invested in the specific technical expertise and regulatory approvals required to run tau imaging.
Research Settings Versus Clinical Care
A significant portion of tau PET scans conducted today occur within research studies rather than routine clinical practice. Patients interested in accessing the scan should be aware of this distinction. A research setting typically means the scan is free or covered by the study, but the patient must meet specific inclusion criteria, which might restrict enrollment based on age, baseline cognitive status, or other factors. Research protocols also usually include baseline cognitive testing and follow-up assessments as part of the study design.
Clinical tau PET—ordered by a patient’s neurologist for diagnostic purposes—is less common but increasingly available. When it is available clinically, insurance coverage remains inconsistent. Medicare and some private insurers have begun to provide coverage in certain circumstances, but coverage is not universal and may depend on the specific indication and the neurologist’s documentation. A warning worth noting: even at centers that perform tau PET clinically, insurance pre-authorization can add weeks to the process, and some insurers may deny the request if the clinical indication does not align with their coverage criteria.
Academic Medical Centers and Neurology Departments
The most reliable way to access tau PET is often through the neurology or neurodegenerative disease department at an academic medical center. These departments typically have access to PET cameras, trained nuclear medicine physicians, and established protocols for image interpretation. Some centers have dedicated “cognitive aging” or “memory disorders” divisions that specifically conduct tau and amyloid imaging as part of routine clinical work-up.
Example: A patient with subjective memory concerns and family history of Alzheimer’s referred to the memory clinic at a major university hospital may be candidates for tau PET as part of a comprehensive biomarker assessment that also includes amyloid imaging, CSF analysis, or MRI. At these centers, the scan is often integrated into a broader diagnostic algorithm rather than offered in isolation. Smaller centers and rural hospitals typically do not have this infrastructure and may refer interested patients to the nearest academic institution.
Accessing Tau PET: Referral and Insurance Considerations
To arrange a tau PET scan, a patient typically needs a referral from a neurologist, primary care physician, or geriatrician. Self-referral to an imaging center is generally not possible because tau PET is a specialized diagnostic test that requires clinical judgment about indication and interpretation. The referring physician must establish that the patient has cognitive or neurological symptoms warranting biomarker imaging. Insurance coverage remains one of the most significant barriers to access.
Medicare has designated certain tau PET tracers for appropriate use cases, but coverage is conditional and varies by tracer and clinical indication. Private insurance varies widely—some cover it under specific circumstances, others do not cover it at all. A patient considering tau PET should expect to contact their insurance company before scheduling to determine whether the test will be covered, what the out-of-pocket cost might be, and what documentation the facility must provide. The imaging center’s billing department can often assist with this pre-authorization process, but delays are common.
Limitations and Practical Challenges
One important limitation is that tau PET results must be interpreted in the full context of a patient’s clinical presentation, other imaging, and cognitive testing. A positive tau PET scan alone does not establish a diagnosis and does not guarantee that the patient will develop dementia or that tau pathology is the cause of current symptoms. Additionally, the meaning of tau positivity varies by location in the brain and the extent of the accumulation, and interpretation requires expertise.
Another practical challenge is that tau PET is time-consuming and costly. The scanning procedure itself takes 30–60 minutes (including radiotracer injection and waiting time), and the full diagnostic evaluation at most centers extends over multiple hours or visits. Out-of-pocket costs can range widely depending on insurance status and facility, and uninsured patients may face rates in the thousands of dollars. This financial barrier means that access to tau PET is not equitable across different income levels or insurance statuses.
Comparing Tau PET to Other Amyloid and Neurodegeneration Imaging
Tau PET differs from amyloid PET in the specific protein it visualizes. Amyloid PET has been available longer and is slightly more widely available than tau imaging. Some centers offer both scans as part of a biomarker assessment, while others may offer only one or the other.
The decision to order tau versus amyloid depends on the clinical situation; tau imaging may be more specific for certain suspected diagnoses, while amyloid is relevant across a broader spectrum of cognitive complaints. Standard MRI and CT remain more universally available and are often performed before PET imaging to assess for other structural causes of cognitive decline (such as stroke or brain atrophy). MRI does not detect tau or amyloid directly but provides complementary anatomical information. PET imaging is much more sensitive to protein pathology but requires access to specialized equipment and expertise.
Finding a Tau PET Service: Practical Steps
The most direct approach is to start with your neurologist or cognitive specialist and ask whether they order tau PET and at which facility. If they don’t, ask for a referral to a facility that does. Alzheimer’s Association chapters in your region can sometimes provide information about research studies and centers offering tau imaging.
The NIH’s ClinicalTrials.gov website allows searching for active tau PET research studies by zip code, which can reveal nearby centers conducting this work. Be prepared for the possibility that the nearest tau PET center may be more than an hour away or that accessing the scan may take several months due to scheduling and pre-authorization delays. Some patients explore participation in research studies specifically to gain access to tau imaging when it is not available clinically in their area. When contacting a facility, confirm not only that they perform tau PET but also whether they accept your insurance and whether the clinical indication for your scan is likely to meet their coverage and protocol requirements.
- —
Frequently Asked Questions
Can I get a tau PET scan without a referral from a neurologist?
No. Tau PET is a specialized diagnostic test that requires a physician’s referral and clear clinical indication. Self-referral to an imaging center is not possible because the scan requires professional interpretation in the context of the patient’s history and other diagnostic findings.
Is tau PET covered by Medicare?
Medicare covers certain tau PET tracers for specific clinical indications, but coverage is conditional and not automatic. Pre-authorization and appropriate clinical documentation are required. Coverage varies by tracer and indication, so verification with your insurance is essential before scheduling.
How much does a tau PET scan cost?
Costs vary widely depending on facility, location, insurance status, and whether the scan is performed in a research or clinical setting. Out-of-pocket costs for uninsured patients can reach several thousand dollars. Insured patients’ costs depend on their plan’s coverage and deductibles.
How is a tau PET scan different from an amyloid PET scan?
Tau PET detects tau protein accumulation, while amyloid PET detects amyloid-beta protein. Both are biomarkers associated with Alzheimer’s disease pathology. Tau imaging may be more specific for certain diagnoses, while amyloid is relevant in a broader range of cognitive scenarios. Availability of each varies by facility.
Can I do a tau PET scan as part of a research study instead of a clinical appointment?
Yes. Many Alzheimer’s research studies include tau PET as part of their protocols. Research studies may cover the cost of imaging and sometimes provide additional cognitive and biomarker testing, though participation requires meeting study inclusion criteria and committing to follow-up visits.
How long does a tau PET scan take?
The imaging procedure itself typically takes 30–60 minutes, including time for radiotracer injection and waiting for optimal imaging conditions. A complete evaluation at most centers extends over several hours or multiple visits when cognitive testing and other assessments are included.
